Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Pharyngeal cancer
Closed
Phase 3
This trial is comparing pembrolizumab with chemotherapy for head and neck cancer that has come back after treatment or spread elsewhere in the body.
Head and neck cancer includes
Cancer in the part of the throat called the hypopharynx (throat cancer)
Recruitment start: 10 April 2015
Recruitment end: 1 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Forster
Merck Sharp & Dohme Ltd
NIHR Clinical Research Network: Cancer
Last reviewed: 18 Apr 2016
CRUK internal database number: 13125
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
